Recombinant Moloney murine leukemia virus Gag polyprotein (gag), partial
-
Catalog numberMBS1031834
-
PricePlease ask
-
Size0.02 mg (E-Coli)
-
-
Products_typeRecombinant Protein
-
Products_short_name[Gag polyprotein]
-
Products_name_syn[Core polyprotein]
-
Other_names[Pr65; Gag polyprotein; Pr65; p15 MA; pp12; p30 CA; p10 NC; Core polyprotein]
-
Products_gene_name[gag]
-
Other_gene_names[gag; gag; Pr65gag; MA; CA; NC-gag]
-
PurityGreater than 90% as determined by SDS-PAGE.
-
FormLyophilized or liquid (Format to be determined during the manufacturing process)
-
Storage_stabilityStore at -20 degree C, for extended storage, conserve at -20 degree C or -80 degree C.
-
SourceRecombinants or rec. proteins
-
Grouprecombinants
-
Gene target
-
Short nameRecombinant Moloney murine leukemia virus Gag polyprotein (gag), partial
-
TechniqueRecombinant, E. coli recombinant proteins are genetic recombinations in Escherichia coli, supplied as white sterile powder lyopillized. MyBioSource advises they will be reconstituted in a buffer soluion or culture medium for cell culture.
-
HostE Coli or Yeast or Baculovirus or Mammalian Cell
-
SpeciesVirus, Viruses
-
Alternative nameRec. Moloney murine leukemia virus Gag polyprotein (gag), partial
-
Alternative techniquerec
-
Virusleukemia
-
MeSH Data
-
Name
-
ConceptScope note: Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues.
-
Tree numbers
- C04.557.337.372
- C04.619.531
- E05.598.500.496.500
-
Qualifiersdiagnosis, parasitology, immunology, microbiology, diagnostic imaging, physiopathology, rehabilitation, enzymology, etiology, mortality, epidemiology, blood, cerebrospinal fluid, chemically induced, congenital, diet therapy, drug therapy, therapy, psychology, urine, virology, history, classification, economics, embryology, genetics, nursing, radiotherapy, ethnology, prevention & control, pathology, metabolism, complications, surgery